1. "Breast Medicine Service"
Formats
  1. Journal Article (2170)
  2. Meeting Abstract (1650)
  3. Review (78)
  4. Book Section (67)
  5. Editorial (42)
  6. Conference Paper (28)
  7. Guidelines (26)
  8. Correspondence (16)
  9. Miscellaneous (11)
  10. Research Letter (10)
  11. Book Whole (5)
Groups
  1. Breast Medicine Service (4103)
  2. Department of Medicine (4103)
  3. Solid Tumor Oncology Division (4103)
  4. Survivorship Research (2337)
  5. GSK Faculty (1492)
  6. Population Sciences Research Program (1339)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (758)
  3. Mark Robson (676)
  4. Neal Rosen (425)
  5. Andrew Seidman (318)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (57)
  2. 2024 (192)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (802)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (169)
  4. Annals of Oncology (158)
  5. Clinical Cancer Research (128)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (853)
  2. American Association for Cancer Research (749)
  3. Springer (329)
  4. Elsevier Inc. (322)
  5. Oxford University Press (278)
  6. Nature Publishing Group (273)

More Publishers

Results (4103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II DORA study of olaparib with or without durvalumab as a chemotherapy-free maintenance strategy in platinum-pretreated advanced triple-negative breast cancer
    Journal Article

    Tan, T. J.; Sammons, S.; Im, Y. H.; She, L.; Mundy, K.; Bigelow, R.; Traina, T. A.; Anders, C.; Yeong, J.; Renzulli, E.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Locoregional therapy for inflammatory breast cancer: How much is enough?
    Meeting Abstract

    Pawloski, K. R.; Diskin, B.; Sevilimedu, V.; Xu, A.; Bromberg, J.; Malhotra, S.; Morrow, M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • BRAF — A tumour-agnostic drug target with lineage-specific dependencies
    Review

    Hanrahan, A. J.; Chen, Z.; Rosen, N.; Solit, D. B.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Management of patients with advanced-stage HER2-positive breast cancer: Current evidence and future perspectives
    Review

    Marra, A.; Chandarlapaty, S.; Modi, S.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The impact of APOE and smoking history on cognitive function in older, long-term breast cancer survivors
    Journal Article

    Ahles, T. A.; Orlow, I.; Schofield, E.; Li, Y.; Ryan, E.; Root, J. C.; Patel, S. K.; McNeal, K.; Gaynor, A.; Tan, H.; more...
    Journal of Cancer Survivorship (2024)

    Fulltext@MSK | Save
  • Wasserstein HOG: Local directionality extraction via optimal transport
    Journal Article

    Zhu, J.; Veeraraghavan, H.; Jiang, J.; Oh, J. H.; Norton, L.; Deasy, J. O.; Tannenbaum, A.
    IEEE Transactions on Medical Imaging (2024)

    Fulltext@MSK | Save
  • Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α
    Journal Article

    Ren, Z.; Dharmaratne, M.; Liang, H.; Benard, O.; Morales-Gallego, M.; Suyama, K.; Kumar, V.; Fard, A. T.; Kulkarni, A. S.; Prystowsky, M.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: Updated survival results from a phase II trial (DESTINY-Breast01)
    Journal Article

    Saura, C.; Modi, S.; Krop, I.; Park, Y. H.; Kim, S. B.; Tamura, K.; Iwata, H.; Tsurutani, J.; Sohn, J.; Mathias, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Mechanisms of exercise intolerance across the breast cancer continuum: A pooled analysis of individual patient data
    Journal Article

    Scott, J. M.; Lee, J.; Michalski, M. G.; Batch, K.; Simpson, A. L.; Peoples, J.; Lee, C. P.; Harrison, J. N.; Yu, A. F.; Sasso, J. P.; more...
    Medicine and Science in Sports and Exercise (2024)

    Fulltext@MSK | Save
  • Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
    Review

    Browne, I. M.; André, F.; Chandarlapaty, S.; Carey, L. A.; Turner, N. C.
    Lancet Oncology (2024)

    Fulltext@MSK | Save